Logo image of ACAN.PA

ACANTHE DEVELOPPEMENT SA (ACAN.PA) Stock Fundamental Analysis

EPA:ACAN - Euronext Paris - Matif - FR0000064602 - REIT - Currency: EUR

0.319  0 (0%)

Fundamental Rating

3

ACAN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 41 industry peers in the Diversified REITs industry. ACAN has a great financial health rating, but its profitability evaluates not so good. ACAN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ACAN had negative earnings in the past year.
In the past year ACAN had a positive cash flow from operations.
In multiple years ACAN reported negative net income over the last 5 years.
Of the past 5 years ACAN 4 years had a positive operating cash flow.
ACAN.PA Yearly Net Income VS EBIT VS OCF VS FCFACAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

ACAN's Return On Assets of -2.99% is on the low side compared to the rest of the industry. ACAN is outperformed by 85.37% of its industry peers.
ACAN has a Return On Equity of -3.54%. This is amonst the worse of the industry: ACAN underperforms 80.49% of its industry peers.
The Return On Invested Capital of ACAN (0.54%) is worse than 90.24% of its industry peers.
Industry RankSector Rank
ROA -2.99%
ROE -3.54%
ROIC 0.54%
ROA(3y)-2.84%
ROA(5y)-1.12%
ROE(3y)-3.39%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ACAN.PA Yearly ROA, ROE, ROICACAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

The Operating Margin of ACAN (23.36%) is worse than 80.49% of its industry peers.
In the last couple of years the Operating Margin of ACAN has grown nicely.
With a Gross Margin value of 73.83%, ACAN perfoms like the industry average, outperforming 51.22% of the companies in the same industry.
ACAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.36%
PM (TTM) N/A
GM 73.83%
OM growth 3YN/A
OM growth 5Y106.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-1.25%
ACAN.PA Yearly Profit, Operating, Gross MarginsACAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACAN is destroying value.
ACAN has more shares outstanding than it did 1 year ago.
ACAN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ACAN is higher compared to a year ago.
ACAN.PA Yearly Shares OutstandingACAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACAN.PA Yearly Total Debt VS Total AssetsACAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 2.62 indicates that ACAN is not a great score, but indicates only limited risk for bankruptcy at the moment.
ACAN has a Altman-Z score of 2.62. This is amongst the best in the industry. ACAN outperforms 97.56% of its industry peers.
ACAN has a debt to FCF ratio of 0.87. This is a very positive value and a sign of high solvency as it would only need 0.87 years to pay back of all of its debts.
ACAN has a Debt to FCF ratio of 0.87. This is amongst the best in the industry. ACAN outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that ACAN is not too dependend on debt financing.
The Debt to Equity ratio of ACAN (0.01) is better than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.87
Altman-Z 2.62
ROIC/WACC0.07
WACC7.84%
ACAN.PA Yearly LT Debt VS Equity VS FCFACAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

ACAN has a Current Ratio of 2.11. This indicates that ACAN is financially healthy and has no problem in meeting its short term obligations.
ACAN has a better Current ratio (2.11) than 92.68% of its industry peers.
ACAN has a Quick Ratio of 2.11. This indicates that ACAN is financially healthy and has no problem in meeting its short term obligations.
ACAN has a Quick ratio of 2.11. This is amongst the best in the industry. ACAN outperforms 92.68% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 2.11
ACAN.PA Yearly Current Assets VS Current LiabilitesACAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

0

3. Growth

3.1 Past

ACAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.08%, which is quite impressive.
The Revenue has decreased by -1.16% in the past year.
ACAN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.49% yearly.
EPS 1Y (TTM)66.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.35%
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y0.44%
Revenue growth 5Y-6.49%
Sales Q2Q%-1.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACAN.PA Yearly Revenue VS EstimatesACAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACAN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACAN.PA Price Earnings VS Forward Price EarningsACAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ACAN is valued a bit more expensive than 73.17% of the companies in the same industry.
Industry RankSector Rank
P/FCF 36.48
EV/EBITDA N/A
ACAN.PA Per share dataACAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACAN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACANTHE DEVELOPPEMENT SA

EPA:ACAN (6/6/2025, 7:00:00 PM)

0.319

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-23 2025-04-23
Earnings (Next)09-22 2025-09-22
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners49.25%
Ins Owner ChangeN/A
Market Cap52.75M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)-46.74%
DP-70.88%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.45
P/FCF 36.48
P/OCF 34.84
P/B 0.47
P/tB 0.47
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY2.74%
OCF(TTM)0.01
OCFY2.87%
SpS0.02
BVpS0.68
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.99%
ROE -3.54%
ROCE 0.74%
ROIC 0.54%
ROICexc 0.57%
ROICexgc 0.57%
OM 23.36%
PM (TTM) N/A
GM 73.83%
FCFM 36.88%
ROA(3y)-2.84%
ROA(5y)-1.12%
ROE(3y)-3.39%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y110.88%
ROICexc growth 3YN/A
ROICexc growth 5Y110.88%
OM growth 3YN/A
OM growth 5Y106.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-1.25%
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.87
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.73%
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 2.11
Altman-Z 2.62
F-Score5
WACC7.84%
ROIC/WACC0.07
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.26%
Cap/Sales(5y)6.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.35%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y0.44%
Revenue growth 5Y-6.49%
Sales Q2Q%-1.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y110.94%
EBIT growth 3YN/A
EBIT growth 5Y93.23%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-65.58%
FCF growth 3YN/A
FCF growth 5Y20.72%
OCF growth 1Y-65.3%
OCF growth 3YN/A
OCF growth 5Y-16.48%